MedTechnique’s consultants are highly experienced industry specialists in market access strategies and reimbursement for medical devices, technologies and services in Australia. When you choose our team you are getting highly experienced specialists who will be dedicated to your project. Our team have the skills and experience that are essential to complete major medical device reimbursement submissions in Australia. We are experts, we are responsive, we communicate clearly and we meet our clients deadlines and financial budget requirements.
Director – MedTechnique Consulting
B.App.Sc (Physio), GradDIp Health Ec & Policy
Sarah Griffin is the founder of MedTechnique Consulting and has more than 25 years of experience in the medical technology sector including health economics, health insurance, health policy and legislation, medical finance, reimbursement systems and government relations. Sarah’s strengths lie in her strategic approach to market access and the creation of effective reimbursement and health economic strategies. She is a registered lobbyist and an expert in preparing complex reimbursement submissions. Since founding MedTechnique Consulting in 2013, she has assisted numerous medical technology companies gain market access for innovative technologies.
She has filled senior and international roles with St Jude Medical, MBF and Mercy Health Services in the United States. Sarah received her B.App Sc (Physio) from the University of Sydney and a GradDip in Health Economics and Policy from Monash University. She has served on several committees of the Medical Technology Association (MTAA) and the Trade and Government Committee of the American Chamber of Commerce. She is a current chair of the committee member of MTAA. She is current chair of the AusMedtech Health Economics Expert Panel and has been appointed by the Australian Government to the Industry Working Group for Prostheses Benefit Reform
Sarah is an experienced speaker and facilitator for industry conferences and corporate events both in Australia and worldwide. She is also experienced in facilitating panels and discussions as part of an event. If you are looking for an experienced health economist with a firm grasp of Australian Health policy for your next event contact us to start the discussion.
Consultant Health Economist
BSc(Hons), GradDipEpi, MAICD
George has more than 25 years of experience in the medical technology and pharmaceutical industries including clinical research, health economics, reimbursement, pricing and business development. He has worked at both local and international levels at senior levels in Australia, Belgium and the United States including Pharmacia, Johnson & Johnson, Schering-Plough and Merck. George established Emerald Corporate Group and has since assisted multiple healthcare companies to successfully gain market access for innovative technologies.
George is expert in developing health economic and reimbursement strategies, strategic pricing initiatives, early assessment of commercial opportunities and preparation of health economic submissions to reimbursement authorities.
George received his BSc[Hons] from the University of Sydney and Grad Dip Epi (Pharmacoepi) from the University of Newcastle. He is a current member of ISPOR and the current Treasurer of ISPOR Australia. He is an active member of ARCS(Australasian Society of Regulatory and Clinical Scientists), HTAi (Health Technology Assessment International), iHEA(Internatiional Health Economics Association) and a member of the AICD(Australian Institute of Company Directors).
BA, BNurse GradDipEcon, MHEcon
Jodie has over 20 years of experience in the health care industry. She has degrees in Nursing, Economics and a Masters in Health Economics. Her background includes Nursing, Qld Health Project Management, retrospective clinical studies, systematic literature reviews and most extensively, Health Economics and Outcomes Research in the Pharmaceutical and Medical Device industry. Jodie specializes in translating medical terminology into effective health care communication for the consumer.
Jodie has worked as an RN in Surgical/Thoracic and Radiation Oncology and has worked in Project Management for Qld Health, auditing and modeling the costs of pressure ulcer prevention in Queensland public hospitals. Jodie was employed by the Australian Centre for Research on Health Economics (ACERH) where she undertook a cost analysis of major trauma in Queensland.
More recently she worked as a Senior Health Economics Analyst at IQVIA in London where Jodie was involved in cost-effectiveness model population, building and design and communication of these results in reports, presentations and manuscripts. She also worked in value communication including the development of multi-country core value dossiers and core reimbursement dossiers, environmental analysis packages, drug reimbursement submissions to the Australian PBAC, the UK NICE (England), SMC (Scotland) and AWMSG (Wales), Poland and the Netherlands.
Jodie now works as a consultant in medical writing and health economics, undertaking literature reviews, data extraction, value dossier chapter writing and MSAC submission writing.
Owner – Veritas Health Economics Consulting
Steve has over 20 years experience in health economic and reimbursement consulting. His clients include pharmaceutical, biotechnology, medical device, and diagnostic companies. Steve is the founder of Veritas Health Economics Consulting and brings a unique combination of health economics expertise, clinical expertise and product development experience gained through senior positions in the consulting and pharmaceutical industries. Steve specialises in developing health economic evaluations including cost-effectiveness analyses, budget impact analyses, decision-analytic models, and Markov models.
He is highly skilled in quantifying and communicating the value of novel and innovative technologies encompassing the fields of oncology, cardiovascular disease, infectious disease, orthopaedics, ophthalmology, obesity, GERD, BPH, and others. Prior to founding Veritas, Steve spent eight years with Covance Health Economics and Outcomes Services where he focused on medical technology assessment, economic modelling, and development of dossiers, manuscripts, and strategic plans. His clients ranged from small start-ups to Fortune 500 companies with technologies in various stages of development and marketing. Steve also has held various positions in pharmaceutical research and clinical development. He spent seven years in research and development at Kendall McGaw and Allergan, primarily in the field of pharmacokinetics. Steve received a Bachelor’s Degree in Biology from the University of California, San Diego and a Master’s Degree in Health Policy and Management from the Harvard School of Public Health.
© MedTechnique Consulting 2021